Sean Bohen
Net worth: 3 M $ as of 2026-07-30
Net worth: 3 M $ as of 2026-07-30
Sean P.
Bohen is President, Chief Executive Officer & Director at Olema Pharmaceuticals, Inc. since 2026, Director at Gyroscope Therapeutics Ltd. since 2020, and Non-Executive Director at AltruBio, Inc. since 2019.
Former roles include Non-Executive Director at Gyroscope Therapeutics Holdings Plc from 2020 to 2022, Senior Vice President-Early Development at Genentech, Inc. from 2003 to 2015, Chief Medical Officer & Executive Vice President at AstraZeneca PLC from 2015 to 2019, and Associate at Howard Hughes Medical Institute, Inc. from 2000 to 2003.
Education includes undergraduate studies at the University of Wisconsin and a doctorate from The University of California, San Francisco.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-22 | 237,650 ( 0.27% ) | 3 M $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Chief Executive Officer | 2020-08-31 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Director/Board Member | 2020-09-10 |
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Director/Board Member | 2019-07-31 |
| Companies | Position | End |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Director/Board Member | 2022-02-16 |
| ASTRAZENECA PLC | Chief Tech/Sci/R&D Officer | 2019-01-13 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 2015-06-30 |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | 2002-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Health Technology |
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Health Technology |
Gyroscope Therapeutics Holdings Plc
Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
Select your edition
All financial news and data tailored to specific country editions